CompletedPhase 4NCT00159419

Bisphosphonate Therapy for Osteogenesis Imperfecta

Studying Idiopathic juvenile osteoporosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Indiana University School of Medicine
Principal Investigator: Linda A DiMeglio, MD, MPH
Indiana University School of Medicine
Intervention: Alendronate(drug)
Enrollment: 18 enrolled
Eligibility: 3-21 years · All sexes
Timeline: 1999 – 2008

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00159419 on ClinicalTrials.gov

← Back to all trials